Velsipity® 2 mg film-coated tablets

*
Pharmacy Only: Prescription
  • Company:

    Pfizer Healthcare Ireland Unlimited Company
  • Status:

    Updated
  • Legal Category:

    Product subject to medical prescription which may not be renewed (A)
  • Active Ingredient(s):

    This medicinal product is subject to additional monitoring.

    *Additional information is available within the SPC or upon request to the company

qrcode image

Scan the QR code or enter an email to access and share this medicine:

Updated on 18 June 2025

File name

clean Adv SPC VL 3_0 IE .pdf

Reasons for updating

  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 10 - Date of revision of the text

Legal category:Product subject to medical prescription which may not be renewed (A)

Free text change information supplied by the pharmaceutical company

The SPC has been updated as follows:

Section 4.4 updated with revised wording for the caution  when co‑administering etrasimod and anti‑neoplastic, immune‑modulating, or immunosuppressive (including corticosteroid) therapies.

Section 10 updated with date of revised text and reference. 

Updated on 18 June 2025

File name

clean Adv PIL VL 3_0 IE .pdf

Reasons for updating

  • Change to section 3 - overdose, missed or forgotten doses
  • Change to section 4 - how to report a side effect
  • Change to section 6 - marketing authorisation holder
  • Change to section 6 - date of revision

Free text change information supplied by the pharmaceutical company

The PIL has been updated as follows:

Section 3, revised text for if you forget to take a dose

Section 4, minor update from “If you get any side effects, talk to your doctor, pharmacist or nurse.” to “If you get any side effects, talk to your doctor or pharmacist.” Deletion of details for United Kingdom (Northern Ireland)

Section 6, Update from Pfizer Healthcare Ireland to Pfizer Healthcare Unlimited Company and Deletion of details for United Kingdom (Northern Ireland). Also, update to revision date and reference

Updated on 07 January 2025

File name

Adv SPC VL 2_5 IE.pdf

Reasons for updating

  • New SPC for new product

Legal category:Product subject to medical prescription which may not be renewed (A)

Free text change information supplied by the pharmaceutical company

Launch Date: 3rd Jan 2025

Updated on 07 January 2025

File name

Adv PIL VL 2_2 IE NI.pdf

Reasons for updating

  • New PIL for new product

Pfizer Healthcare Ireland Unlimited Company

Pfizer Healthcare Ireland Unlimited Company